Shortages of Vyvanse (lisdexamfetamine dimesilate) capsules

Takeda Pharmaceuticals Australia have notified us that Vyvanse 20 mg capsules are now in shortage and they expect Vyvanse 60 mg capsules to be in shortage from late August 2024. These shortages are due to higher-than-normal demand for these strengths of Vyvanse capsules. 

We acknowledge the significant impact the shortage of Vyvanse capsules has on people who rely on these medicines, as well as their carers and health care professionals. 

Please visit our About the shortages of Vyvanse (lisdexamfetamine dimesilate) capsules webpage and our Medicine shortage reports database for up-to-date information.

For specific information about the supply of Vyvanse capsules, please contact Takeda directly.